Low environmental levels of neuro-active pharmaceuticals alter phototactic behaviour and reproduction in Daphnia magna.
Assessing the risks of emerging contaminants, such as pharmaceuticals in the environment requires an understanding of their exposure regime and their effects at environmentally relevant concentrations across species. Daphnia magna represents an excellent invertebrate model species to study the mode of action of emerging pollutants, allowing the assessment of effects at different biological levels. The present study aims to test the hypothesis that different families of neuro-active pharmaceuticals at low environmentally relevant concentrations may lead to similar phenotypic responses in D. magna. Phenotypic traits included reproduction and behavioural responses. Selected pharmaceuticals were carbamazepine, diazepam and propranolol, three widely prescribed compounds, already detected at considerable levels in the environment (ng to few μg/L). Fluoxetine was also included in behavioural assays. The three tested neuro-active pharmaceuticals were able to enhance reproduction at 1ng/L of propranolol, 0.1μg/L of diazepam and 1μg/L of carbamazepine. Fluoxetine, carbamazepine and diazepam increased positive phototactic behaviour at concentrations ranging from 1, 10 and 100ng/L, respectively. Reported responses were nonmonotonic, which means that eco-toxicity testing of pharmaceuticals need to assess effects at the ng/L range.
Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain.
Claudia
C
Rivetti
Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain.
Bruno
B
Campos
Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain. Electronic address: cbmqam@cid.csic.es.
Carlos
C
Barata
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002220:Carbamazepine / Q000032:analysis / Q000302:isolation & purification / Q000633:toxicity; D002851:Chromatography, High Pressure Liquid; D003621:Daphnia / Q000502:physiology*; D005473:Fluoxetine / Q000032:analysis / Q000302:isolation & purification / Q000633:toxicity; D008027:Light; D011433:Propranolol / Q000032:analysis / Q000302:isolation & purification / Q000633:toxicity; D012098:Reproduction / Q000187:drug effects*; D052616:Solid Phase Extraction; D021241:Spectrometry, Mass, Electrospray Ionization; D018675:Toxicity Tests; D014874:Water Pollutants, Chemical / Q000032:analysis / Q000302:isolation & purification / Q000633:toxicity*
D014874:Water Pollutants, Chemical; D005473:Fluoxetine; D002220:Carbamazepine; D011433:Propranolol
Beta-blockers; Carbamazepine; Crustacean; Diazepam; Neuroendocrine; Population